Keywords: novartis, sales, up, eight, product, launches, due

Novartis' sales up 17% to $7.2 B in 2006, with eight product launches due in 2007

Article | 29 January 2007

Print This

Swiss drug major Novartis said that a strong health care portfolio and continued innovation in its pharmaceutical development operations had ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in